Working with Industry
Based in Ireland, we are the internationally-focused Science Foundation Ireland research center for chronic and rare neurological disease linking innovative neurotherapeutics development with genomic and biomarker-based patient stratification enabled by a national eHealth infrastructure. We connect SME and multinational industry partners with leading Irish scientists in neurological investigation and a research-active clinical network to design and deliver patient-centred translational research.
Real-world data to inform molecular diagnostics and targeted therapeutics
Technology for rapid point-of-care diagnostics
Neuronal stem cell technology to discover drug treatments
Novel screening models for disease modifying treatments
Companion nanotechnology solutions for the delivery of therapies to affected brain region
eHealth technology for improved care pathways
Gene therapy, large molecules across the blood brain barrier
Basic mechanisms of neurological disease
RNA-targeting therapeutics to restore normal brain excitability
Precision medicines and infrastructure for translation to the clinic
Molecular biomarkers for acquired and rare, genetically-defined epilepsies and Motor Neurone Disease
Our areas of expertise
With our core skills in neuroscience, clinical neurology, genetics, cell biology, materials chemistry, patient care and patient data analytics across seven academic institutions we bring expertise in a number of areas.
Through our academic and clinical partners, we have access to state-of-the-art research infrastructure. Our ability to combine and apply these technologies across our themes of Diagnosis, Therapeutics and eHealth makes us distinctive and excellent.
Key enablers for our translational research
Biosamples and Biobanking
Engaging with FutureNeuro
We invite partnerships with SMEs and multinational pharmaceutical and biomedical companies in sectors covering:
- digital and biological biomarkers
- diagnostic tools
- therapeutic discovery and development
- eHealth-enabled patient support platforms
- clinical trials.
Partnering opportunities with us can include:
- Fully-funded collaborations
- Jointly-funded collaborations
- Joint applications for research funding (eg. H2020, NIH)
- Participation in national Centre expansion programmes (e.g. DTIF, BESTS)
We have in-depth experience in industry engagement, technology transfer, IP management and commercialisation. We work closely with the relevant State Agencies and can support partners to obtain appropriate state funding mechanisms.
To discuss a research partnership with FutureNeuro, please contact:
Bridget Doyle Business Development and Centre Manager t: +353 1 402 5061 m: +353 87 683 7203 e: email@example.com
Hover to see our partners
Our current projects with industry partners focus on bringing diagnostic supports to market, developing and testing pipeline of new drugs, and expanding connected health solutions to enable patients and their clinicians co-monitor their health better than ever before.